{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-068591","form_type":"8-K","ticker":"OVID","cik":"0001636651","company_name":"Ovid Therapeutics Inc.","filed_at":"2023-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.893586+00:00","generated_at":"2026-06-07T17:07:36.996744+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Ovid Therapeutics CEO gifts 1.15M shares to family trusts for estate planning","bullets":["CEO Jeremy Levin gifted 1,146,500 shares of Ovid common stock to family trusts for his two daughters.","After gift, Dr. Levin holds 3,598,467 shares of outstanding common stock.","Transfers made for no consideration as part of year-end estate tax planning.","Form 4 filed with SEC on December 6, 2023 reporting the gifts."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-068591","json":"https://secwatch.observer/filing/0000950170-23-068591.json","markdown":"https://secwatch.observer/filing/0000950170-23-068591.md","text":"https://secwatch.observer/filing/0000950170-23-068591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/0000950170-23-068591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/ovid-20231204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T17:07:36.996744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}